NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Total Liabilities | ₹880 Cr | ₹793 Cr | ₹739 Cr | ₹157 Cr | ₹119 Cr |
What is the latest Total Liabilities ratio of NATH BIOGENES (INDIA) ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹880 Cr |
Mar2023 | ₹793 Cr |
Mar2022 | ₹739 Cr |
Mar2013 | ₹157 Cr |
Mar2012 | ₹119 Cr |
How is Total Liabilities of NATH BIOGENES (INDIA) Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹880 Cr | 11.03 | |
Mar2023 | ₹793 Cr | 7.21 | |
Mar2022 | ₹739 Cr | 369.87 | |
Mar2013 | ₹157 Cr | 32.15 | |
Mar2012 | ₹119 Cr | - |
Compare Total Liabilities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹288.9 Cr | -7.9% | -14.6% | -27.5% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,941.3 Cr | -4.7% | -6.4% | 7.1% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,017.6 Cr | -0.3% | 5.7% | 43.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,307.4 Cr | -1.4% | -4.7% | -4.5% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,520.8 Cr | -0.1% | 4.8% | -42.3% | Stock Analytics | |
TIERRA AGROTECH | ₹301.4 Cr | -12.4% | -16.7% | -41.7% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -7.9% |
-14.6% |
-27.5% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses